S

SRRK

SRRK

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
100%Bullish
Buy/Sell Ratio100% buys
BearishBullish
SRRK Live QuoteReal-time
$50.37
+$7.37(+17.14%)1M
Day Range$47.95 – $50.72
Open$47.95
Previous Close$48.00
Volume2.45M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$6.15B
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-3.23
Price to Book34.7
Dividend Yield0.65%
Beta (Volatility)0.79
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $50.37 (51%)
Low: $38.69High: $61.76
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$70.06-53.3% upside

Insider Buys

1

$12.00M

Insider Sales

0

$0

Total Volume

$12.00M

1 transactions

Net Activity

+$12.00M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
80CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Ultra-high accumulation: total purchase value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
A
1

Akkaraju Srinivas

Dir

1 buys0 sells

$12.00M total

Trading History
SRRK insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 23, 2026

4 weeks ago

Akkaraju Srinivas

Dir

Director
Buy289.5K$41.45$12.00M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
SRRK Buy Conviction100%
Industry Rank#0 of 569
Volume Contribution0.1%
Total Industry Activity$16.52B

SRRK has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for SRRK

Over the last 90 days, corporate insiders at SRRK (SRRK) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $12.00M.

The net insider activity for SRRK shows a net buying bias of $12.00M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Purchase by Akkaraju Srinivas (Dir), who traded 289.5K shares valued at $12.00M on Oct 23, 2026.

Live Market News & Developments
Aggregated real-time headlines for SRRK (SRRK)
6 updates

Scholar Rock (SRRK) Stock Fair Value Edges Higher After Isembyld Approval And Analyst Revisions

Yahoo Finance66d ago

Scholar Rock gains as investors continue to digest early ISEMBYLD launch traction and PRV sale

Quiver Quantitative23h ago

SRRK - Scholar Rock Holding Corp Stock Price and Quote

Finviz178d ago

Scholar Rock (NASDAQ:SRRK) Stock Price Crosses Above 50 Day Moving Average - Time to Sell?

MarketBeatYesterday

Scholar Rock (SRRK) Stock Looks Stretched On ISEMBYLD Launch Progress

Simply Wall St9d ago

SRRK Stock Gains After Company Drops Troubled Novo Nordisk-Owned Plant From FDA Filing

Yahoo Finance91d ago

FAQs About SRRK Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for SRRK.

Based on SEC Form 4 disclosures, the Insider Confidence Score for SRRK is currently 80/100, which reflects a strong accumulation bias. This calculation accounts for a total of 1 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for SRRK is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.